Germline and nonsilent somatic mutations in the exonuclease proofreading domains of POLD1 predispose patients to develop hypermutated sporadic and colitis‐associated CRC.[22] We found POLD1 was correlated with c‐Myc. The gene discussed is MYC; the disease is colorectal carcinoma.